Patients infected with HIV type 1 subtype CRF01_AE and failing first-line nevirapine- and efavirenz-based regimens demonstrate considerable cross-resistance to etravirine

感染 HIV-1 亚型 CRF01_AE 且一线奈韦拉平和依非韦伦方案治疗失败的患者对依曲韦林表现出显著的交叉耐药性。